Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

PDO threads improve skin firmness and elasticity with minimal recovery time.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

PRP heals pockmarked skin better than salmon DNA serum.

PRS injections can improve knee function and reduce pain for up to a year.

A woman got a serious eye infection after a hair loss treatment due to improper procedure.

CTP-543 is generally safe for treating alopecia areata.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Combining PRF and PDO threads shows promise in treating male pattern baldness.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Encapsulated pumpkin seed protein improves aloe vera drink's taste, antioxidants, and shelf life.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Combination therapy promotes better hair growth and density.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Keratosis pilaris significantly affects quality of life and shows specific skin changes.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

Combining povidone iodine and diode laser speeds up wound healing and infection control in mice.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.